EMERGING INTERVENTIONS & THERAPIES FOR EFFECTIVE DENGUE MANAGEMENT

The review delves into the latest developments in dengue fever treatment, particularly focusing on emerging therapies such as vaccines and host-directed therapies (HDTs) designed to bolster the immune response to the virus. It outlines the progress in vaccine research, with a particular emphasis on the introduction of Dengvaxia, the first licensed dengue vaccine, and highlights ongoing efforts to develop more effective vaccines that offer broader protection across different serotypes of the virus. The review also underscores the importance of a holistic approach to managing dengue fever. It argues that alongside medical interventions, factors such as dietary considerations and community engagement are crucial in prevention strategies. It stresses the need for integrated public health initiatives that empower local communities to take proactive measures in controlling mosquito populations and reducing the risk of transmission. Furthermore, the review calls for sustained research efforts and collaboration across multiple sectors, including healthcare professionals, scientists, and policymakers. By fostering international cooperation, the hope is to develop innovative solutions that can effectively reduce the global burden of dengue fever. The ultimate goal is not only to advance vaccine development but also to implement comprehensive strategies that combine prevention, treatment, and community involvement, ensuring that global health initiatives are robust and sustainable in the fight against dengue fever.